Sterling Pharma to invest $1.5m in US facility expansion

SourceCleanroom Technology
Date Published10/29/2019
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Sterling Pharma Solutions US
Parent companySterling Pharma Solutions
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Capital investment ($):1.5
Country(ies) from which reshored:United Kingdom
State(s) reshored to:NC
If relevant, work nearshored to:-
Product(s) reshoredpharmaceuticals
What domestic positive factors made reshoring more attractive?Eco-system synergies, Infrastructure, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market, Skilled workforce availability/training
Find Reshoring Articles